Questionnaires in gastroesophageal reflux disease: What do the answers mean?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 8, 2009, Pages 1311-1312

  Holloway, Richard H ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; CLINICAL ASSESSMENT; CLINICAL EVALUATION; EDITORIAL; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HEARTBURN; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY;

EID: 69049092782     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.05931.x     Document Type: Editorial

References (22)

1. Sharma P, Chey WD, Hunt R, Laine L, Malfertheiner P, Wani S. Endoscopy of the esophagus in gastroesophageal reflux disease: are we losing sight of symptoms? Another perspective. Dis. Esophagus 2009 10 : 1 6.
2. Talley N, Dennis E, Schettler-Duncan V, Lacy B, Olden K, Crowell M. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am. J. Gastroenterol. 2003 98 : 2454 2459.
3. Carlsson R, Dent J, Bolling-Sternevald E et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand. J. Gastroenterol. 1998 33 : 1023 1029.
4. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. A new questionnaire for gastroesophageal reflux disease. Mayo Clin. Proc. 1994 69 : 539 547.
5. Liu JY, Woloshin S, Laycock WS, Rothstein RI, Finlayson SR, Schwartz LM. Symptoms and treatment burden of gastroesophageal reflux disease: validating the GERD assessment scales. Arch. Int. Med. 2004 164 : 2058 2064.
6. Sandmark S, Carlsson R, Fausa O, Lundell L. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study. Scand. J. Gastroenterol. 1988 23 : 625 632.
7. McColl E, Junghard O, Wiklund I, Revicki DA. Assessing symptoms in gastroesophageal reflux disease: how well do clinicians' assessments agree with those of their patients? Am. J. Gastroenterol. 2005 100 : 11 18.
8. Johnsson F, Roth Y, Damgaard Pedersen NE, Joelsson B. Cimetidine improves GERD symptoms in patients selected by a validated GERD questionnaire. Aliment. Pharmacol. Ther. 1993 7 : 81 6.
9. Rothman M, Farup C, Stewart W, Helbers L, Zeldis J. Symptoms associated with gastroesophageal reflux disease: development of a questionnaire for use in clinical trials. Dig. Dis. Sci. 2001 46 : 1540 1549.
10. Williford WO, Krol WF, Spechler SJ. Development for and results of the use of a gastroesophageal reflux disease activity index as an outcome variable in a clinical trial. VA Cooperative Study Group on Gastroesophageal Reflux Disease (GERD). Control. Clin. Trials 1994 15 : 335 348.
11. Armstrong D, Monnikes H, Bardhan KD, Stanghellini V. The construction of a new evaluative GERD questionnaire - methods and state of the art. Digestion 2004 70 : 71 8.
12. Pool M. Review article: gastroesophageal reflux disease - application of the concept of complete remission. Aliment. Pharmacol. Ther. 2007 26 (Suppl. 2) 13 16.
13. Carlsson R, Frison L, Lundell L, Dent J. Relationship between symptoms, endoscopic esophagitis and treatment outcome in reflux esophagitis. Gastroenterology 1996 110 : A77.
14. Avidan B, Sonnenberg A, Schnell TG, Sontag SJ. Risk factors for erosive reflux esophagitis: a case-control study. Am. J. Gastroenterol. 2001 96 : 41 6.
15. Fennerty MB, Johnson DA. Heartburn severity does not predict disease severity in patients with erosive esophagitis. Med. Gen. Med. 2006 8 : 6.
16. Locke GR, Zinsmeister AR, Talley NJ. Can symptoms predict endoscopic findings in GERD? Gastrointest. Endosc. 2003 58 : 661 670.
17. Johnson DA, Fennerty MB. Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease. Gastroenterology 2004 126 : 660 664.
18. Kusano M, Shimoyama Y, Sugimoto S et al. Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J. Gastroenterol. 2004 39 : 888 891.
19. Miyamoto M, Haruma K, Takeuchi K, Kuwabara M. Frequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of prokinetics to proton pump inhibitor therapy. J. Gastroenterol. Hepatol. 2008 23 : 746 751.
20. Fujimoto F, Danjo A, Kusano M. Comparison of the degree of correlation with endoscopic findings between the frequency scale for the symptoms of gastroesophageal reflux disease (FSSG) and the questionnaire for the diagnosis of reflux esophagitis QUEST): a multicentre Japanese study. J. Gastroenterol. Hepatol. 2009 24 : 633 638.
21. Rubin G, Uebel P, Brimo-Hayek A, Hey KH, Doerfler H, Heading RC. Validation of a brief symptom questionnaire (ReQuest in Practice) for patients with gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther. 2008 27 : 846 851.
22. Numans ME, de Wit NJ. Reflux symptoms in general practice: diagnostic evaluation of the Carlsson-Dent gastro-oesophageal reflux disease questionnaire. Aliment. Pharmacol. Ther. 2003 17 : 1049 1055.